BDSI BioDelivery Services started with a Buy at Ferris Baker; tgt $7 (1.89 )
Ferris Baker Watts initiates BDSI with a Buy and $7 tgt. Firm believes that within the universe of publicly traded "drug-delivery" cos, BDSI is relatively inexpensive, based on the potential rev of its pipeline, and the relatively low risk of its projects under development. Firm favors the co's drug development strategy as the co applying its core technology to create improved versions of safe and effective generic drugs. Depending on the drug, these improvements can include increased speed of action, oral availability of a drug normally administered intravenously, and enhanced shelf life and chemical stability. They note that because drugs under consideration are all widely used in man, the time required to develop these "improved" versions is dramatically reduced, as are the cumulative costs involved in FDA mandated clinical studies.
Thanks the $7 price target is reasonable & conservative IMO.
4.4mill shares just sold at 2 in the pub offering and you also have a boatload of insider buying which started in the $3 a share range. I should also add insiders already own a big chunk of this company. I like to see over 10% at least and we have over 50% ownership. prior to the recent offering it was over 90%. The stock is absolutely being given away at these current prices.